EMEA-002479-PIP01-18-M01
Key facts
| Active substance |
Narsoplimab
|
| Therapeutic area |
Haematology-Hemostaseology
|
| Decision number |
P/0370/2021
|
| PIP number |
EMEA-002479-PIP01-18-M01
|
| Pharmaceutical form(s) |
Solution for injection/infusion
|
| Condition(s) / indication(s) |
Treatment in haematopoietic stem cell transplantation
|
| Route(s) of administration |
Intravenous use
|
| Contact for public enquiries |
Omeros Ireland Limited
E-mail: regulatory@omeros.com |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|